Federated Hermes, Inc. Cure Vac N.V. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.5 - $10.77 $65,000 - $107,700	10,000 Added 33.33%	40,000 $273,000
Q2 2023 Aug 14, 2023	SELL	$6.69 - $12.25 $66,900 - $122,500	-10,000 Reduced 25.0%	30,000 $312,000
Q1 2023 May 08, 2023	BUY	$6.38 - $12.5 $255,200 - $500,000	40,000 New	40,000 $278,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $2,227 - $3,280	-169 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $2,489 - $5,957	169 New	169 $3,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.